Saltar al contenido
Merck

Inhibitory and antimicrobial activities of OGTI and HV-BBI peptides, fragments and analogs derived from amphibian skin.

Peptides (2012-04-21)
Dawid Dębowski, Rafał Łukajtis, Anna Łęgowska, Natalia Karna, Michał Pikuła, Magdalena Wysocka, Irena Maliszewska, Marcin Sieńczyk, Adam Lesner, Krzysztof Rolka
RESUMEN

A series of linear and cyclic fragments and analogs of two peptides (OGTI and HV-BBI) isolated from skin secretions of frogs were synthesized by the solid-phase method. Their inhibitory activity against several serine proteinases: bovine β-trypsin, bovine α-chymotypsin, human leukocyte elastase and cathepsin G from human neutrophils, was investigated together with evaluation of their antimicrobial activities against Gram-negative bacteria (Escherichia coli) and Gram-positive species isolated from patients (Staphylococcus aureus, Staphylococcus epidermidis, Enterococcus sp., Streptococcus sp.). The cytotoxicity of the selected peptides toward an immortal human skin fibroblast cell line was also determined. Three peptides: HV-BBI, its truncated fragment HV-BBI(3-18) and its analog [Phe(8)]HV-BBI can be considered as bifunctional compounds with inhibitory as well as antibacterial properties. OGTI, although it did not display trypsin inhibitory activity as previously reported in the literature, exerted antimicrobial activity toward S. epidermidis. In addition, under our experimental conditions, this peptide did not show cytotoxicity.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Cathepsin G from human leukocytes, lyophilized powder, ≥60 units/mg protein (Bradford)